StockWatch
·
Pharmaceuticals
Board Meeting27 Oct 2026, 12:57 pm

Themis Medicare Board Meeting on Nov 5 to Approve Un-audited Results

AI Summary

Themis Medicare Limited has announced that its Board of Directors will convene on November 5, 2026. The primary agenda for this meeting is to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting will also review the Limited Review Reports from the Statutory Auditors. Concurrently, the company has informed its 'Designated Persons' about the closure of the Trading Window from October 1, 2026, until 48 hours after the financial results are published, in compliance with SEBI's Insider Trading Regulations.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve un-audited standalone and consolidated financial results.
  • Results for the quarter and half-year ended September 30, 2026.
  • Trading window to remain closed for designated persons.
  • Compliance with SEBI Insider Trading Regulations.